Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CALC
CALC | US
0.73
USD0.00
0.56%
CALC | US
Loading StockChartView...
About CALC
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.73
Open
0.73
High
0.77
Low
0.70
CalciMedica Inc. a clinical-stage biotechnology company focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis asparaginase-associated acute pancreatitis and acute kidney injury. The company is based in La Jolla California.
View LessCALC | US
Risk
116.7
Sharpe
-0.55
Luna's Score
42/100
Recommendation
Sell
Luna says (CALC | US)
What's Working
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
107.3%1 month
116.7%3 months
202.4%6 months
155.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.17
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.26
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-21.39M
MarketCap
7.86M
MarketCap(USD)
7.86M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-83.76
Short ratio
0.65
Short perc.
0.65
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.32
Range1M
0.33
Range3M
6.74
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.58
Price X volume
227.67K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.26 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.17 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 202.44 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 7.86M | 3.66B | Emerging |
